Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at $227.68 as of March 11th. ABBV’s trailing and forward P/E were 96.07 and 15.65 respectively according to Yahoo Finance.
Copyright: mikkolem / 123RF Stock Photo
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing,...
